Search

everythinglearnresearchcommunity

for

Search:↓

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

High BMI worsens hair growth in women with PCOS.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Spironolactone most effective for hirsutism, but has side effects.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Flutamide reduces hair growth better but has more side effects.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.